Kong v. Fluidigm Corporation

Background

Kwok Kong was appointed lead plaintiff in a proposed securities class action against Fluidigm Corporation, Stephen Christopher Linthwaite, and Vikram Jog. The proposed class consisted of people and entities that purchased or otherwise acquired Fluidigm securities between February 7, 2019, and November 5, 2019.

Kong alleged that the defendants made materially false or misleading statements, and failed to disclose adverse information, about Fluidigm’s business and prospects. The allegations focused on the company’s mass-cytometry business, including allegedly overpriced products, an overly general marketing strategy, increased competition from Cytek, longer sales cycles, delayed or lost sales, and inaccurate revenue guidance. Kong alleged that these statements artificially inflated Fluidigm’s stock price and that the price fell after later disclosures.

The amended complaint asserted two claims: a claim under Section 10(b) of the Securities Exchange Act and Securities and Exchange Commission Rule 10b-5 against all defendants, and a Section 20(a) control-person claim against Linthwaite and Jog.

Judicial Notice

The court granted defendants’ request for judicial notice of Fluidigm’s Securities and Exchange Commission reports, earnings-call transcripts, and other filings. The court explained that these documents were referenced in the amended complaint, were central to the claims, and were not challenged as authentic. The court agreed with Kong, however, that judicial notice did not permit the court to accept disputed facts in those documents as true or use the documents to resolve factual disputes.

Motion-to-Dismiss Standards

The court reviewed the amended complaint under Federal Rules of Civil Procedure 8, 9(b), and 12(b)(6), as well as the heightened pleading requirements of the Private Securities Litigation Reform Act. Rule 12(b)(6) tests whether a complaint states a legally sufficient claim. Rule 9(b) requires fraud allegations to identify the circumstances of the alleged fraud with particularity. The Private Securities Litigation Reform Act separately requires private securities-fraud complaints to plead falsity and scienter—the intent to deceive or deliberate recklessness—with particularity.

For a Section 10(b) and Rule 10b-5 claim, the plaintiff must adequately allege a material misrepresentation or omission, scienter, a connection to the purchase or sale of a security, reliance, economic loss, and loss causation. Defendants did not challenge Kong’s allegations concerning the last four elements, so the court addressed only falsity and scienter.

Falsity

The court held that Kong did not adequately plead that the challenged statements were false when made. The allegations about Cytek’s effect on Fluidigm’s sales did not specifically connect the confidential witnesses’ information to particular statements or establish what the individual defendants knew and when they knew it. The allegations that Fluidigm’s products were overpriced and its marketing approach was flawed were unsupported opinions rather than particularized facts showing that statements were misleading.

The court also noted that Fluidigm exceeded revenue guidance in two quarters and missed guidance by two percent in the final quarter of the proposed class period. In the court’s view, those results undermined the claim that the company’s statements were false when made.

The court further ruled that several challenged statements were non-actionable corporate puffery. Statements such as saying that Fluidigm was well positioned for growth, had a solid backlog, or was a market leader were vague expressions of optimism rather than specific factual representations on which a securities-fraud claim could rest.

The court also applied the Private Securities Litigation Reform Act’s safe harbor for identified forward-looking statements accompanied by meaningful cautionary language. The challenged statements about future growth, sales opportunities, demand, and business performance were forward-looking. Fluidigm’s filings and earnings calls warned about risks including fluctuating demand, difficult-to-forecast results, dependence on mass cytometry, and increased competition. The court found those warnings sufficient to bring the statements within the safe harbor, making them non-actionable.

Scienter

The court held that the amended complaint also failed to plead scienter. Although the confidential witnesses were described with sufficient detail to establish their job responsibilities and tenure, their accounts did not show that the individual defendants made statements indicating an intent to deceive or deliberate recklessness. Allegations that executives attended meetings, received reports, or had access to sales information were insufficient by themselves.

The court rejected reliance on the “core operations” doctrine, which can support an inference that senior executives knew facts central to a company’s business. The complaint did not allege specific admissions showing that the individual defendants were involved in the company’s operational details or helped prepare false reports. The court also noted that Linthwaite purchased Fluidigm shares during the relevant period, and there were no allegations of suspicious insider sales.

Considering the allegations as a whole, the court found that they did not create a strong inference that the defendants intended to deceive investors. The company’s competitive difficulties and internal strategic disagreements, together with a decline in its stock price, did not by themselves establish securities fraud.

Section 20(a) Claim

Section 20(a) imposes control-person liability when a person controls someone who committed a primary securities-law violation. Because Kong failed to plead the underlying Section 10(b) violation, the court held that he also failed to state a Section 20(a) claim against the individual defendants.

Disposition

The court granted defendants’ request for judicial notice and granted defendants’ motion to dismiss the amended complaint with leave to amend. Kong was given 21 days from the date of the order to file a second amended complaint addressing the identified deficiencies. The court stated that no new claims or parties could be added without the court’s permission or the agreement of all parties.